Multiple Myeloma Face-Off: Ken Shain, MD, PhD, and Ravi Vij, MD, MBA, on ASH 2022

EP. 1: Expert Recaps Recent Research and Evolving Paradigms in Multiple Myeloma

December 19th 2022

Ken Shain, MD, PhD, discussed some of the research in multiple myeloma that was featured in a recent FaceOff program, and how these recent advances may change the standard of care.

EP. 2: Expert Highlights Practice-Changing Effects of Immunotherapies in Multiple Myeloma

December 19th 2022

Ken Shain, MD, PhD, spoke about the dramatic impact of novel immunotherapies in the multiple myeloma treatment landscape, as well as other updates from the 2022 ASH Annual Meeting and Exposition.

EP. 3: Forecasting the Future of Multiple Myeloma

December 19th 2022

Ken Shain, MD, PhD, provides an overview of developments on the horizon in multiple myeloma.

EP. 4: Access, Access, Access: Unmet Needs in Multiple Myeloma

December 20th 2022

Ken Shain, MD, PhD, pinpoints the critical, lingering gaps in patient access to cellular immunotherapies in multiple myeloma.